Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA171640
Max Phase: Preclinical
Molecular Formula: C19H25ClN2O3
Molecular Weight: 364.87
Molecule Type: Small molecule
Associated Items:
ID: ALA171640
Max Phase: Preclinical
Molecular Formula: C19H25ClN2O3
Molecular Weight: 364.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NCCN1CCOCC1)c1cc(Cl)cc2c1OC1CCCCC21
Standard InChI: InChI=1S/C19H25ClN2O3/c20-13-11-15-14-3-1-2-4-17(14)25-18(15)16(12-13)19(23)21-5-6-22-7-9-24-10-8-22/h11-12,14,17H,1-10H2,(H,21,23)
Standard InChI Key: IQRVVSJZXLQUGR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 364.87 | Molecular Weight (Monoisotopic): 364.1554 | AlogP: 2.82 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.80 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.70 | CX Basic pKa: 5.90 | CX LogP: 2.62 | CX LogD: 2.61 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.89 | Np Likeness Score: -0.90 |
1. Youssefyeh RD, Campbell HF, Airey JE, Klein S, Schnapper M, Powers M, Woodward R, Rodriguez W, Golec S, Studt W.. (1992) Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides., 35 (5): [PMID:1548679] [10.1021/jm00083a015] |
Source(1):